Author's Organization：Graduate Course of Applied Chemistry, Sojo University (Former Name: Kumamoto Institute of Technology) Graduate Course of Applied Chemistry, Sojo University (Former Name: Kumamoto Institute of Technology) Graduate Course of Applied Chemistry, Sojo University (Former Name: Kumamoto Institute of Technology) Graduate Course of Applied Chemistry, Sojo University (Former Name: Kumamoto Institute of Technology) Graduate Course of Applied Chemistry, Sojo University (Former Name: Kumamoto Institute of Technology)
Published: October 01, 2000Received: May 19, 2000Available on J-STAGE: April 10, 2008Accepted: August 04, 2000
Advance online publication: -
Revised: -
Significantly prolonged survival rate was obtained for the first time using carcinoma mice models after the administration of single-component liposomes of dimyristoylphosphatidylcholine(DMPC) without any drug. An increase in lymphocytes under optical microscope was observed without any increase in the neutrophils count, suggesting that the DMPC liposomes might inhibit the tumor growth as well as increase in lymphocytes in vivo.
